Live data · NADAC + Part D CY24 · reviewed daily

Benztropine

Anticholinergic class · 12 generic manufacturers · 28 ANDAs filed at FDA.

First FDA approval1992-01-23
Generic availableYes · 12 mfrs
Shortage statusDiscontinued
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$35.4M in CY2024 Part D spend2.9M claims · 455K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.063/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.066
Across all dosage forms in distribution.
Highest NADAC
$0.075
Range is tight.
Plans with PA
348 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Benztropine used for?

Benztropine is a Anticholinergic medication tracked in Medicare Part D.

Is there a generic for Benztropine?

Yes. 28 ANDAs filed at FDA, 12 generic manufacturers currently shipping.

How much does my plan pay for Benztropine?

Across 329 Part D plans, Benztropine averages $0.066/unit (NADAC). Lowest available: $0.063/unit. Highest in distribution: $0.075/unit.

Is Benztropine on the FDA shortage list?

Benztropine has been discontinued by its manufacturer(s).

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Anticholinergic6 alternatives in D1
01
Atropine
Brand: ATROPEN Auto-Injector
$4.08Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Atropine Injection,
Anticholinergic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Glycopyrrolate
Brand: Cuvposa
$0.101Lowest NADAC
35Generic mfrs
$15.4MCY24 Part D spend
Compare →
05
Ipratropium
Brand: Atrovent
$0.108Lowest NADAC
10Generic mfrs
$244.7MCY24 Part D spend
Compare →
06
Ipratropium and Albuterol
Brand: Combivent Respimat
$0.086Lowest NADAC
4Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh14 Jul 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.